Medivolve Inc. MEDVF
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 682.70K | 522.60K | 604.10K | 711.40K | 7.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 682.70K | 522.60K | 604.10K | 711.40K | 7.68M |
| Cost of Revenue | -36.90K | -30.40K | -58.10K | -6.10K | 4.07M |
| Gross Profit | 719.60K | 553.00K | 662.20K | 717.50K | 3.61M |
| SG&A Expenses | 4.02M | 4.25M | 5.32M | 5.46M | 14.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.98M | 4.22M | 5.26M | 5.46M | 18.15M |
| Operating Income | -3.30M | -3.70M | -4.65M | -4.74M | -10.47M |
| Income Before Tax | -2.96M | -3.65M | -4.91M | -5.66M | -11.98M |
| Income Tax Expenses | -- | -- | -- | -- | -2.89M |
| Earnings from Continuing Operations | -2.96 | -3.65 | -4.91 | -5.66 | -9.09 |
| Earnings from Discontinued Operations | -7.95M | -8.67M | -4.15M | -6.03M | -6.03M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 193.60K | 140.40K | 100.60K | -- | -- |
| Net Income | -10.72M | -12.18M | -8.96M | -11.68M | -15.11M |
| EBIT | -3.30M | -3.70M | -4.65M | -4.74M | -10.47M |
| EBITDA | -3.06M | -3.37M | -4.32M | -3.91M | -9.56M |
| EPS Basic | -0.40 | -0.45 | -0.33 | -0.43 | -0.56 |
| Normalized Basic EPS | -0.08 | -0.09 | -0.11 | -0.12 | -0.25 |
| EPS Diluted | -0.40 | -0.45 | -0.34 | -0.43 | -0.56 |
| Normalized Diluted EPS | -0.08 | -0.09 | -0.11 | -0.12 | -0.25 |
| Average Basic Shares Outstanding | 108.08M | 108.08M | 108.07M | 108.07M | 108.07M |
| Average Diluted Shares Outstanding | 108.08M | 108.08M | 108.07M | 108.07M | 108.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |